Timo Gemoll

1.0k total citations
44 papers, 531 citations indexed

About

Timo Gemoll is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Timo Gemoll has authored 44 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Timo Gemoll's work include Genetic factors in colorectal cancer (9 papers), Advanced Proteomics Techniques and Applications (8 papers) and Cancer Genomics and Diagnostics (6 papers). Timo Gemoll is often cited by papers focused on Genetic factors in colorectal cancer (9 papers), Advanced Proteomics Techniques and Applications (8 papers) and Cancer Genomics and Diagnostics (6 papers). Timo Gemoll collaborates with scholars based in Germany, Sweden and United States. Timo Gemoll's co-authors include Jens K. Habermann, Uwe J. Roblick, Gert Auer, Thomas Ried, Christoph Thorns, Hans‐Peter Bruch, Hans Jörnvall, Ulf Hellman, Ralph Pries and Susanne Becker and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Timo Gemoll

39 papers receiving 526 citations

Peers

Timo Gemoll
Melissa M. Johnson United States
Hankui Chen United States
Matthew Winans United States
Shalini Makawita United States
Timo Gemoll
Citations per year, relative to Timo Gemoll Timo Gemoll (= 1×) peers Yingfu Liu

Countries citing papers authored by Timo Gemoll

Since Specialization
Citations

This map shows the geographic impact of Timo Gemoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Gemoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Gemoll more than expected).

Fields of papers citing papers by Timo Gemoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Gemoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Gemoll. The network helps show where Timo Gemoll may publish in the future.

Co-authorship network of co-authors of Timo Gemoll

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Gemoll. A scholar is included among the top collaborators of Timo Gemoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Gemoll. Timo Gemoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kramer, Mario W., Axel S. Merseburger, Sivahari Prasad Gorantla, et al.. (2024). Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells. Cell Communication and Signaling. 22(1). 129–129. 3 indexed citations
3.
Pasternack, Helen, Timo Gemoll, Christiane Kümpers, et al.. (2023). Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors. Scientific Reports. 13(1). 20948–20948. 2 indexed citations
4.
Kohl, Michael M., Justyna M. Kowal, Hagen Schmal, et al.. (2022). Protein Expression of AEBP1, MCM4, and FABP4 Differentiate Osteogenic, Adipogenic, and Mesenchymal Stromal Stem Cells. International Journal of Molecular Sciences. 23(5). 2568–2568. 8 indexed citations
5.
Kakkassery, Vinodh, Timo Gemoll, Aysegül Tura, et al.. (2022). Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma. International Journal of Molecular Sciences. 23(7). 4058–4058. 6 indexed citations
6.
Kiefer, Selina, et al.. (2022). Systematic evaluation and optimization of protein extraction parameters in diagnostic FFPE specimens. Clinical Proteomics. 19(1). 10–10. 10 indexed citations
7.
Heselmeyer‐Haddad, Kerstin, Daniela Hirsch, Wei‐Dong Chen, et al.. (2021). Single Cell Genetic Profiling of Tumors of Breast Cancer Patients Aged 50 Years and Older Reveals Enormous Intratumor Heterogeneity Independent of Individual Prognosis. Cancers. 13(13). 3366–3366. 9 indexed citations
9.
Freitag‐Wolf, Sandra, Timo Gemoll, Kerstin Heselmeyer‐Haddad, et al.. (2020). Genome Instability Profiles Predict Disease Outcome in a Cohort of 4,003 Patients with Breast Cancer. Clinical Cancer Research. 26(17). 4606–4615. 9 indexed citations
10.
Gemoll, Timo, Christian Röder, Sonja Hartwig, et al.. (2020). Protein Profiling of Serum Extracellular Vesicles Reveals Qualitative and Quantitative Differences after Differential Ultracentrifugation and ExoQuick™ Isolation. Journal of Clinical Medicine. 9(5). 1429–1429. 16 indexed citations
11.
Schaake, Susen, Karen Grütz, Inke R. König, et al.. (2020). DNA Methylation as a Potential Molecular Mechanism in X‐linked Dystonia‐Parkinsonism. Movement Disorders. 35(12). 2220–2229. 6 indexed citations
12.
Gemoll, Timo, et al.. (2019). Spatial UBE2N protein expression indicates genomic instability in colorectal cancers. BMC Cancer. 19(1). 710–710. 7 indexed citations
13.
Braun, Rüdiger, Scott Ronquist, Darawalee Wangsa, et al.. (2019). Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression. Neoplasia. 21(4). 401–412. 22 indexed citations
14.
Kunz, Natalia, Brent T. Xia, Kai‐Uwe Kalies, et al.. (2017). Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential. Shock. 48(3). 346–354. 9 indexed citations
15.
Gemoll, Timo, Gert Auer, Thomas Ried, & Jens K. Habermann. (2015). Genetic Instability and Disease Prognostication. Recent results in cancer research. 200. 81–94. 5 indexed citations
16.
Gemoll, Timo, Oliver Löwe, Mats Borén, et al.. (2013). The impact of pre-analytical conditions on the serum proteome: heat-stabilization versus nitrogen storage. Archives of Physiology and Biochemistry. 119(3). 100–107. 2 indexed citations
17.
Lomnytska, Marta, Susanne Becker, Timo Gemoll, et al.. (2012). Impact of genomic stability on protein expression in endometrioid endometrial cancer. British Journal of Cancer. 106(7). 1297–1305. 31 indexed citations
18.
Gemoll, Timo, Jens K. Habermann, Silke Szymczak, et al.. (2011). Protein profiling of genomic instability in endometrial cancer. Cellular and Molecular Life Sciences. 69(2). 325–333. 7 indexed citations
19.
Gemoll, Timo, Uwe J. Roblick, Gert Auer, Hans Jörnvall, & Jens K. Habermann. (2010). SELDI-TOF serum proteomics and colorectal cancer: A current overview. Archives of Physiology and Biochemistry. 116(4-5). 188–196. 25 indexed citations
20.
Roblick, Uwe J., Franz G. Bader, Lalle Hammarstedt‐Nordenvall, et al.. (2008). Proteomic analysis of protein expression in human tonsillar cancer differentially expressed proteins characterize human tonsillar cancer. Acta Oncologica. 47(8). 1493–1501. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026